Segment disclosures

Company overview

일신바이오

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 15 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2020-07-01 – 2020-09-304023326818 KRW20201116Open filing evidence
2020-01-01 – 2020-09-3014038702321 KRW20201116Open filing evidence
2020-04-01 – 2020-06-304930643536 KRW20210817Open filing evidence
2020-01-01 – 2020-06-3010015357343 KRW20210817Open filing evidence
2020-01-01 – 2020-03-315084713807 KRW20200514Open filing evidence
2019-01-01 – 2019-12-3119635658054 KRW20200330Open filing evidence
2019-07-01 – 2019-09-308013354263 KRW20201116Open filing evidence
2019-01-01 – 2019-09-3015337112585 KRW20201116Open filing evidence
2019-04-01 – 2019-06-304873801837 KRW20210817Open filing evidence
2019-01-01 – 2019-06-307323758322 KRW20210817Open filing evidence
2019-01-01 – 2019-03-312449956485 KRW20200514Open filing evidence
2018-01-01 – 2018-12-3115383067066 KRW20200330Open filing evidence
2018-07-01 – 2018-09-303248243826 KRW20191101Open filing evidence
2018-01-01 – 2018-09-3010053373652 KRW20191101Open filing evidence
2017-01-01 – 2017-12-3112836996414 KRW20200330Open filing evidence